Are you Dr. Gold?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 Madison St
Seattle, WA 98104Phone+1 206-386-2323Fax+1 206-386-2729
Summary
- Dr. Philip Gold, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington.
Education & Training
- University of Miami Leonard M. Miller School of MedicineClass of 1991
Certifications & Licensure
- WA State Medical License 1993 - 2027
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients WithWild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial.Kanwal Pratap Singh Raghav, Katherine A Guthrie, Benjamin Tan Jr, Crystal S Denlinger, Marwan Fakih
Journal of Clinical Oncology. 2025-01-06 - 3 citationsSunitinib in Patients With Breast Cancer WithorAmplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
JCO Precision Oncology. 2024-02-01 - 12 citationsPembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
Journal of Clinical Oncology. 2023-11-20